itntdfI have not been following a closely as I used to do. There are other things to do, garden et cetera.
My take is as follows: The 5 million accelerator award enables a clinical trial with pela and modified FOLFIRINOX with and without an ICI. This grant was a surprise and renders the 90 day thing no longer a thing. If succesful this trial gets added into the Precision Promise Trial. The potential patient population will be much larger. It is worth the wait. There are a lot of moving parts here.
It will take a bit of time; we cannot afford any mistakes.
Best.